UPDATE: Needham & Company Upgrades Acadia Pharmaceuticals (ACAD) to Buy, $9 Price Target

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/3/2026

1. SPY
2. MSTR
3. KKR
4. CVX
5. ITGR
6. CL
7. GTM
8. ARES
9. PLTR
10. SPCX

Go back to UPDATE: Needham & Company Upgrades Acadia Pharmaceuticals (ACAD) to Buy, $9 Price Target
Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) Delayed: 25.79 -0.08 (0.31%)
Previous Close $25.87    52 Week High $42.49 
Open $25.96    52 Week Low $16.64 
Day High $26.11    P/E N/A 
Day Low $25.63    EPS $-0.42 
Volume 195,279